Chevy Chase Trust’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-8,391
Closed -$605K 645
2022
Q1
$605K Sell
8,391
-166,460
-95% -$12M ﹤0.01% 591
2021
Q4
$16.1M Sell
174,851
-175,317
-50% -$21M 0.05% 314
2021
Q3
$44.4M Sell
350,168
-34,618
-9% -$5.04M 0.15% 137
2021
Q2
$64M Sell
384,786
-88,992
-19% -$14.4M 0.22% 105
2021
Q1
$86.1M Buy
473,778
+12,548
+3% +$2.91M 0.31% 81
2020
Q4
$92.2M Sell
461,230
-12,458
-3% -$2.53M 0.33% 68
2020
Q3
$104M Buy
473,688
+6,138
+1% +$1.3M 0.41% 51
2020
Q2
$89.2M Sell
467,550
-38,281
-8% -$6.71M 0.36% 64
2020
Q1
$78.4M Buy
505,831
+46,842
+10% +$5.45M 0.36% 72
2019
Q4
$38.4M Buy
458,989
+39,694
+9% +$3.02M 0.15% 153
2019
Q3
$28.4M Buy
419,295
+123,670
+42% +$8.14M 0.12% 192
2019
Q2
$19.6M Buy
295,625
+98,143
+50% +$5.72M 0.08% 258
2019
Q1
$11.2M Buy
+197,482
New +$12.1M 0.05% 382

Other funds holding TDOC

Chevy Chase Trust's TDOC Position: Q2 2022 in Review

Chevy Chase Trust sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 8,391 shares — an estimated $605K sold.

Chevy Chase Trust first reported a position in TDOC in Q1 2019 and held it in 13 quarters. The position peaked at $104M in Q3 2020. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Chevy Chase Trust reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • Chevy Chase Trust sold 8,391 Teladoc Health shares in Q2 2022, an estimated $605K.
  • Chevy Chase Trust first reported a position in Teladoc Health in Q1 2019 and held it in 13 quarters.
  • Chevy Chase Trust's Teladoc Health position peaked at $104M in Q3 2020.
  • 551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Chevy Chase Trust's 13F filing for Q2 2022, filed 10 Aug 2022.